August 2020—Microbiologics announced the launch of two products for COVID-19 quality control and research—a research use only protein-coated RNA process control and an IVD control with pooled gene targets.
The SARS-CoV-2 control features diagnostically relevant RNA sequences protected by phage protein, providing nuclease resistance even in nuclease-rich environments such as nasal secretions or plasma. The control features genomic targets for all seven WHO COVID-19 testing protocols and can be used for SARS-CoV-2 assay development, positive extraction, and spike-in controls. It contains human respiratory epithelial cells to verify the complete testing process.
The company is also launching the SARS-CoV-2 Helix Elite control, which features a pool of large RNA molecules that match the viral sequences for the RdRp, S, E, and N gene targets. The pooled genetic targets offer broad compatibility with CDC- and WHO-specified test components to generate positive PCR signals.
Microbiologics, 800-599-2847